, 2017 Aspergillus is a mould genus frequently isolated in cases of fungal infections among patients at tertiary hospitals worldwide. Currently, the genus is composed of about 350 species, being more than 40 already described as a human pathogen in diverse ...
Negri, Clara Ezequiel [UNIFESP]
core
Management of invasive candidiasis: A focus on rezafungin, ibrexafungerp, and fosmanogepix
Management of invasive fungal infections is challenging with growing antifungal resistance. Broad antifungal use has resulted in greater intrinsic and acquired resistance among Candida spp.
Kale-Pradhan, Pramodini B +1 more
core +1 more source
Recent drug development and treatments for fungal infections. [PDF]
Braz J Microbiol, 2023 Roy M +3 more
europepmc +1 more source
Novel Promising Antifungal Target Proteins for Conquering Invasive Fungal Infections. [PDF]
Front Microbiol, 2022 Zhen C, Lu H, Jiang Y.
europepmc +1 more source
Emerging and future strategies in the management of recalcitrant Candida auris. [PDF]
Med Mycol, 2022 Bandara N, Samaranayake L.
europepmc +1 more source
Safety and Pharmacokinetics of Intravenous and Oral Fosmanogepix, a First-in-Class Antifungal Agent, in Healthy Volunteers. [PDF]
Antimicrob Agents Chemother, 2023 Hodges MR +8 more
europepmc +1 more source
Phase 1b safety and pharmacokinetics of intravenous and oral fosmanogepix in patients with acute myeloid leukaemia and neutropenia. [PDF]
J Antimicrob Chemother, 2023 Cornely OA +8 more
europepmc +1 more source
Advances in cryptococcal infections-associated immunopathology and potential therapeutic strategies. [PDF]
Front PharmacolSachivkina N +6 more
europepmc +1 more source
Fungal Sphingolipids: Biosynthesis Pathways, Structural Features and Biological Functions. [PDF]
J Fungi (Basel)Xue Z, Wang L, Du C.
europepmc +1 more source
<i>Candida auris</i>: a review of global epidemiology, multidrug resistance, and infection control in healthcare-associated outbreaks. [PDF]
Front Cell Infect MicrobiolDu X, Li L.
europepmc +1 more source